Phase 1 Clinical Trial of a New Antiarrhythmic Drug ME3202.

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.19.169
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Clinic Phase I Study of a New ClassI Antiarrhythmic Drug, Moracizine(En-313).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1995English

New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2011English

A Review On: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2017English

Therapeutic Drug Monitoring: Antiarrhythmic Drugs

British Journal of Clinical Pharmacology
Pharmacology
1998English

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy in the Vanish Trial

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Pneumonitis and Pulmonary Fibrosis Associated With Amiodarone Treatment: A Possible Complication of a New Antiarrhythmic Drug

Circulation
Cardiovascular MedicinePhysiologyCardiology
1982English

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Propafenone: A Promising New Antiarrhythmic Agent

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1990English

Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy